Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Masking and Demasking Agents01:19

Masking and Demasking Agents

EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...
Effects of EDTA on End-Point Detection Methods01:18

Effects of EDTA on End-Point Detection Methods

Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2003
Same author

Structure of bacteriocin AS-48: from soluble state to membrane bound state.

Journal of molecular biology·2003
Same author

Crural artery bypass with the autogenous greater saphenous vein.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2003
Same author

[Predictive value of prenatal MRI in the diagnosis of thoracic congenital malformations].

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2003
Same author

Weekly paclitaxel for advanced non-small cell lung cancer patients not suitable for platinum-based therapy.

Neoplasma·2003
Same author

Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control.

Diabetic medicine : a journal of the British Diabetic Association·2003
Same journal

The bad effects of noise.

The Pharmaceutical journal·2010
Same journal

Penicillin cream.

The Pharmaceutical journal·2010
Same journal

The stability of penicillin solutions.

The Pharmaceutical journal·2010
Same journal

Vaccines and sera.

The Pharmaceutical journal·2010
Same journal

The present status of varicose vein sclerosing agents.

The Pharmaceutical journal·2010
Same journal

Small scale ampoule work.

The Pharmaceutical journal·2010
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Trace metals and chemotherapy

A ALBERT

    The Pharmaceutical Journal
    |March 19, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    CHEMOTHERAPYMETABOLISM/trace elementsMETALS/metabolism

    More Related Videos

    Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
    05:36

    Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

    Published on: February 23, 2024

    Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells
    13:04

    Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells

    Published on: May 16, 2019

    Related Experiment Videos

    Last Updated: Jun 14, 2026

    Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
    11:14

    Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

    Published on: November 10, 2013

    Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
    05:36

    Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

    Published on: February 23, 2024

    Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells
    13:04

    Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells

    Published on: May 16, 2019